Corista Receives Frost & Sullivan’s 2014 Product Innovation Award for Digital Pathology
Frost & Sullivan sees building digital connections between physicians and their patients as the future of pathology and awards Corista its New Product Innovation Leadership Award in Image-Centric Workflow Platforms for Digital Pathology. According to Frost & Sullivan, within seven years, most laboratories will switch to a digitized pathology workflow. However, there remain a number of challenges within digital pathology that extend beyond the mere digitization of pathology images, including interconnectivity between geographic locations and devices, and providing efficiency in collaborative work.
Based on its recent analysis of the image-centric workflow platforms market, Frost & Sullivan recognizes Corista with the 2014 North America Frost & Sullivan Award for New Product Innovation. Corista’s DP3 platform significantly improves image management for digital pathology by being a unified system, connecting scanners of all makes and models to pathologists within an organization and across the world.
Using the hardware-agnostic DP3, a pathologist or a physician can access slide images and offer diagnosis from any location on any browser-enabled device, including mobile tablets. This platform enables smaller, remote facilities to have their digital images read by external experts, regardless of location or the scanner they are using.
For this award, Frost & Sullivan evaluated Corista for visionary innovation and excellence that reflected in multiple areas:
– Addressing key unmet challenges
– Matching market needs
– Providing a solution to meet Mega Trends
– Value and quality of product/service
– Pioneering best practices
“DP3 not only offers browser-based access from any connected device, but also aids the gathering and search of structured data through its customer-configurable synoptic reporting,” said Frost & Sullivan Senior Industry Analyst Divyaa Ravishankar. “Its image-centric approach is also user-centric, with clean, intuitive interfaces that improve its ease of use and adoptability. DP3’s synchronized viewing and collaboration capabilities allow pathologists to collaborate on cases in real time or within their regular workflows.”
To learn more about Frost & Sullivan’s forecasted trends in the digital pathology market and how Corista’s DP3 platform addresses them, download the full Frost & Sullivan report by clicking here.
About Frost & Sullivan:
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?